Valley National Advisers Inc. Sells 371 Shares of CVS Health Co. (NYSE:CVS)

Valley National Advisers Inc. cut its position in shares of CVS Health Co. (NYSE:CVS) by 1.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,272 shares of the pharmacy operator’s stock after selling 371 shares during the quarter. Valley National Advisers Inc.’s holdings in CVS Health were worth $2,074,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Live Oak Investment Partners purchased a new position in shares of CVS Health during the fourth quarter worth approximately $25,000. Atticus Wealth Management LLC lifted its stake in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. Cornerstone Planning Group LLC grew its stake in shares of CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 243 shares during the last quarter. PCA Investment Advisory Services Inc. purchased a new position in shares of CVS Health in the second quarter worth about $37,000. Finally, ZRC Wealth Management LLC boosted its holdings in CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have weighed in on CVS. Cantor Fitzgerald reiterated an “overweight” rating and issued a $87.00 price objective on shares of CVS Health in a research report on Thursday. SVB Leerink assumed coverage on shares of CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price target on the stock. Leerink Partnrs reiterated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Royal Bank of Canada decreased their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Finally, StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Stock Performance

CVS Health stock traded down $0.18 during mid-day trading on Monday, reaching $74.40. 2,120,519 shares of the stock traded hands, compared to its average volume of 11,120,963. The stock has a market capitalization of $93.63 billion, a PE ratio of 11.54, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The business’s 50-day moving average is $76.08 and its 200-day moving average is $73.78. CVS Health Co. has a 12-month low of $64.41 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. CVS Health’s revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.99 EPS. As a group, sell-side analysts predict that CVS Health Co. will post 8.33 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.58%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is currently 41.18%.

Insider Transactions at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.25% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.